Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ESJAY PHARMA

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 65
  • 0 comments

FDA approve ATENOLOL

Comment Full text

ESJAY PHARMA

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 69
  • 0 comments

FDA approve ATENOLOL

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 64
  • 0 comments

FDA approve ASPIRIN; DIPYRIDAMOLE

Comment Full text

GRAVITI PHARMS

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 60
  • 0 comments

FDA approve LORAZEPAM

Comment Full text

UNIQUE

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 64
  • 0 comments

FDA approve ATENOLOL

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • July 31, 2025, 08:51 UTC
  • 63
  • 0 comments

FDA approve BUPRENORPHINE HYDROCHLORIDE

Comment Full text

CODADOSE INC

  • FDA Approval
  • July 30, 2025, 22:28 UTC
  • 82
  • 0 comments

FDA approve CELECOXIB

Comment Full text

CELLTRION INC

  • FDA Approval
  • July 30, 2025, 22:08 UTC
  • 79
  • 0 comments

FDA approve TOCILIZUMAB-ANOH

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • July 30, 2025, 08:47 UTC
  • 68
  • 0 comments

FDA approve CEFEPIME HYDROCHLORIDE

Comment Full text

PTC THERAP

  • FDA Approval
  • July 29, 2025, 16:11 UTC
  • 81
  • 0 comments

FDA approve SEPIAPTERIN

Comment Full text
  • Previous
  • 115
  • 116
  • 117
  • 118
  • 119
  • Next

Search

News categories

  • Technical Exchange News(13480)
  • Event(6229)
  • SEC News(347328)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192056)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin